Literature DB >> 25239086

An evaluation of treatment integrity in a randomised controlled trial of memory rehabilitation for people with multiple sclerosis.

Kathryn J Smale1, Sara E Carr2, Annette F Schwartz2, Roshan das Nair3, Nadina B Lincoln3.   

Abstract

OBJECTIVE: To assess the treatment integrity of a memory rehabilitation programme for people with multiple sclerosis.
SUBJECTS: Data were drawn from the intervention group of a randomised controlled trial of memory rehabilitation. This comprised 24 participants with multiple sclerosis. MEASURES: Four core session components were identified from the treatment manual: recap, activities, take-home activity and other. One video-recording of each of ten intervention sessions was transcribed and amount of time spent on components recorded.
RESULTS: There were no significant differences between early and late stages of the programme in time spent on the core components (recap Z= -0.87, P=0.49; activities Z = -0.29, P=0.89; take-home activity Z = -0.59, P=0.69; other Z = -0.58, P=0.69). Thus, adherence to the manual was good with no evidence of programme drift.
CONCLUSIONS: Good adherence indicates the intervention was delivered as described in the manual and strengthens confidence in the findings of the randomised controlled trial.
© The Author(s) 2014.

Entities:  

Keywords:  Memory rehabilitation; multiple sclerosis; process evaluation; treatment integrity

Mesh:

Year:  2014        PMID: 25239086     DOI: 10.1177/0269215514548733

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  2 in total

1.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

2.  Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).

Authors:  Nadina B Lincoln; Roshan das Nair; Lucy Bradshaw; Cris S Constantinescu; Avril E R Drummond; Alexandra Erven; Amy L Evans; Deborah Fitzsimmons; Alan A Montgomery; Miriam Morgan
Journal:  Trials       Date:  2015-12-08       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.